Colchicine for secondary prevention of ischaemic stroke and atherosclerotic events: a meta-analysis of randomised trials

Aernoud T.L. Fiolet(University Medical Center Utrecht), Peter J. Kelly(University College Dublin), Jan H. Cornel(Brigham and Women's Hospital), Georgios Tsivgoulis(National and Kapodistrian University of Athens), Robin Lemmens(VIB-KU Leuven Center for Microbiology), Christian Weimar(Institut für Medizinische Informatik, Biometrie und Epidemiologie), Christopher Price(Newcastle University), Michiel H.F. Poorthuis(University Medical Center Utrecht), Cathal Walsh(Trinity College Dublin), Ian Buysschaert(AZ Sint-Jan), Arend Mosterd(Werkgroep Cardiologische centra Nederland), Jean‐Claude Tardif(Montreal Heart Institute), Binita Shah(New York University), Tjerk S.J. Opstal(Amsterdam University Medical Centers), Noel Chan(Chinese University of Hong Kong), Charley Budgeon(The University of Western Australia), Domingo A. Pascual‐Figal(Spanish National Centre for Cardiovascular Research), Jamie Layland(Peninsula Health), Stefan M. Nidorf(Harry Perkins Institute of Medical Research), John W. Eikelboom(Population Health Research Institute), Kevin E. Boczar(University of Ottawa), Yongjun Wang(Shanghai University of Traditional Chinese Medicine), Peter L. Thompson(Sir Charles Gairdner Hospital), Jan G.P. Tijssen(University of Amsterdam), Nathan Mewton(Hospices Civils de Lyon), Pierre Amarenco(Population Health Research Institute), Sanjit S. Jolly(Population Health Research Institute)
EClinicalMedicine
October 1, 2024
Cited by 56


Related Papers